Construction will begin this year with the new capacity anticipated by 2025
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
To enable company to be future-ready by tapping potential in CDMO space
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
This industry-academia collaboration will provide students with an opportunity to participate in research activities with multiple international universities and scientists
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Subscribe To Our Newsletter & Stay Updated